Artículos de revistas sobre el tema "DltX"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "DltX".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Poyart, Claire, Marie Cécile Lamy, Claire Boumaila, Franz Fiedler y Patrick Trieu-Cuot. "Regulation of d-Alanyl-Lipoteichoic Acid Biosynthesis in Streptococcus agalactiae Involves a Novel Two-Component Regulatory System". Journal of Bacteriology 183, n.º 21 (1 de noviembre de 2001): 6324–34. http://dx.doi.org/10.1128/jb.183.21.6324-6334.2001.
Texto completoDebabov, Dmitri V., Michael Y. Kiriukhin y Francis C. Neuhaus. "Biosynthesis of Lipoteichoic Acid inLactobacillus rhamnosus: Role of DltD ind-Alanylation". Journal of Bacteriology 182, n.º 10 (15 de mayo de 2000): 2855–64. http://dx.doi.org/10.1128/jb.182.10.2855-2864.2000.
Texto completoBeeh, K. M., O. Kornmann, J. Lill y R. Buhl. "Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function". Thorax 56, n.º 7 (1 de julio de 2001): 557–60. http://dx.doi.org/10.1136/thx.56.7.557.
Texto completoWood, B. McKay, John P. Santa Maria, Leigh M. Matano, Christopher R. Vickery y Suzanne Walker. "A partial reconstitution implicates DltD in catalyzing lipoteichoic acid d-alanylation". Journal of Biological Chemistry 293, n.º 46 (20 de septiembre de 2018): 17985–96. http://dx.doi.org/10.1074/jbc.ra118.004561.
Texto completoDu, Liqin y Yu Luo. "Thiolation-enhanced substrate recognition by D-alanyl carrier protein ligase DltA from Bacillus cereus". F1000Research 3 (13 de mayo de 2014): 106. http://dx.doi.org/10.12688/f1000research.4097.1.
Texto completoDavidsen, Jesper Rømhild, Hans Henrik Lawaetz Schultz, Daniel Pilsgaard Henriksen, Martin Iversen, Anna Kalhauge, Jørn Carlsen, Michael Perch, Ole Graumann y Christian B. Laursen. "Lung Ultrasound in the Assessment of Pulmonary Complications After Lung Transplantation". Ultraschall in der Medizin - European Journal of Ultrasound 41, n.º 02 (9 de noviembre de 2018): 148–56. http://dx.doi.org/10.1055/a-0783-2466.
Texto completoLee, In-Gyun, Chiman Song, Seoyeong Yang, Hanul Jeon, Jingyeong Park, Hye-Jin Yoon, Hookang Im, Sung-Min Kang, Hyun-Jong Eun y Bong-Jin Lee. "Structural and functional analysis of the D-alanyl carrier protein ligase DltA from Staphylococcus aureus Mu50". Acta Crystallographica Section D Structural Biology 78, n.º 4 (16 de marzo de 2022): 424–34. http://dx.doi.org/10.1107/s2059798322000547.
Texto completoKoprivnjak, Tomaz, Vid Mlakar, Lindsey Swanson, Benedicte Fournier, Andreas Peschel y Jerrold P. Weiss. "Cation-Induced Transcriptional Regulation of the dlt Operon of Staphylococcus aureus". Journal of Bacteriology 188, n.º 10 (15 de mayo de 2006): 3622–30. http://dx.doi.org/10.1128/jb.188.10.3622-3630.2006.
Texto completoKlein, Uwe, Waheedullah Karzai, Frank Bloos, Mathias Wohlfarth, Reiner Gottschall, Harald Fritz, Michael Gugel y Albrecht Seifert. "Role of Fiberoptic Bronchoscopy in Conjunction with the Use of Double-lumen Tubes for Thoracic Anesthesia". Anesthesiology 88, n.º 2 (1 de febrero de 1998): 346–50. http://dx.doi.org/10.1097/00000542-199802000-00012.
Texto completoZhong, Wei, Roberto Bugarini, Ling Wang, Cynthia Basu y Darrin M. Beaupre. "Rethinking about the dose limiting toxicities (DLTs): They can be equivocal!" Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 3064. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3064.
Texto completoMthethwa, Sthembile y Morne Pretorius. "Academic and Skills Credentialing Using Distributed Ledger Technology (DLT) and W3C Standards: Technology Assessment". International Conference on Intelligent and Innovative Computing Applications 2022 (31 de diciembre de 2022): 170–82. http://dx.doi.org/10.59200/iconic.2022.019.
Texto completoKiriukhin, Michael Y. y Francis C. Neuhaus. "d-Alanylation of Lipoteichoic Acid: Role of the d-Alanyl Carrier Protein in Acylation". Journal of Bacteriology 183, n.º 6 (15 de marzo de 2001): 2051–58. http://dx.doi.org/10.1128/jb.183.6.2051-2058.2001.
Texto completoSpatafora, Grace A., Megan Sheets, Rebecca June, David Luyimbazi, Katherine Howard, Robin Hulbert, Daron Barnard, Mariam el Janne y Michael C. Hudson. "Regulated Expression of the Streptococcus mutans dltGenes Correlates with Intracellular Polysaccharide Accumulation". Journal of Bacteriology 181, n.º 8 (15 de abril de 1999): 2363–72. http://dx.doi.org/10.1128/jb.181.8.2363-2372.1999.
Texto completoSoltani, Reza, Marzia Zaman, Rohit Joshi y Srinivas Sampalli. "Distributed Ledger Technologies and Their Applications: A Review". Applied Sciences 12, n.º 15 (6 de agosto de 2022): 7898. http://dx.doi.org/10.3390/app12157898.
Texto completoCostello, Brian Addis, Yingwei Qi, Mitesh J. Borad, George P. Kim, Donald W. Northfelt, Charles Erlichman y Steven R. Alberts. "Phase I trial of everolimus, gemcitabine and cisplatin for patients with solid tumors refractory to standard therapy." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e13052-e13052. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e13052.
Texto completoJha, Sachin y Jesse M. Ehrenfeld. "Double Lumen Tubes: Usage and Performance by Frequent and Infrequent Users". ISRN Anesthesiology 2011 (1 de noviembre de 2011): 1–4. http://dx.doi.org/10.5402/2011/586592.
Texto completoMehlis, Katja, Elena Bierwirth, Katsiaryna Laryionava, Friederike Mumm, Pia Heussner y Eva C. Winkler. "Late decisions about treatment limitation in patients with cancer: empirical analysis of end-of-life practices in a haematology and oncology unit at a German university hospital". ESMO Open 5, n.º 5 (octubre de 2020): e000950. http://dx.doi.org/10.1136/esmoopen-2020-000950.
Texto completoShin, Hyejin, Jung-Eun Ha, Dae Young Zang, Sung-Hyun Kim, Young Rok Do, Won Sik Lee, Soo-Hyun Kim et al. "Clinical Response Evaluation Toward Individualizing the Starting Dose of Dasatinib in Asian Patients with Chronic Myeloid Leukemia". Blood 136, Supplement 1 (5 de noviembre de 2020): 6. http://dx.doi.org/10.1182/blood-2020-140626.
Texto completoHunaiti, Ziad. "Digital Learning Technologies". International Journal of Handheld Computing Research 8, n.º 2 (abril de 2017): 41–50. http://dx.doi.org/10.4018/ijhcr.2017040103.
Texto completoZimmermann, Tanja. "End-of-Life: Patientinnen und Patienten rechtzeitig einbinden". Kompass Onkologie 8, n.º 2 (2021): 84–85. http://dx.doi.org/10.1159/000516879.
Texto completoZimmermann, Tanja. "End-of-Life: Patientinnen und Patienten rechtzeitig einbinden". Kompass Pneumologie 9, n.º 6 (2021): 308–9. http://dx.doi.org/10.1159/000519230.
Texto completoZimmermann, Tanja. "End-of-Life: Patientinnen und Patienten rechtzeitig einbinden". Kompass Dermatologie 9, n.º 3 (2021): 134–35. http://dx.doi.org/10.1159/000517944.
Texto completoNurgazina, Jamilya, Udsanee Pakdeetrakulwong, Thomas Moser y Gerald Reiner. "Distributed Ledger Technology Applications in Food Supply Chains: A Review of Challenges and Future Research Directions". Sustainability 13, n.º 8 (9 de abril de 2021): 4206. http://dx.doi.org/10.3390/su13084206.
Texto completoMatsuo, Miki, Yuichi Oogai, Fuminori Kato, Motoyuki Sugai y Hitoshi Komatsuzawa. "Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus". Microbiology 157, n.º 6 (1 de junio de 2011): 1786–97. http://dx.doi.org/10.1099/mic.0.044727-0.
Texto completoCoupri, Delphine, Aurélie Budin-Verneuil, Axel Hartke, Abdellah Benachour, Loïc Léger, Thierry Lequeux, Emmanuel Pfund y Nicolas Verneuil. "Genetic and pharmacological inactivation of d-alanylation of teichoic acids sensitizes pathogenic enterococci to β-lactams". Journal of Antimicrobial Chemotherapy 74, n.º 11 (24 de julio de 2019): 3162–69. http://dx.doi.org/10.1093/jac/dkz322.
Texto completoInnocenti, Federico, Richard L. Schilsky, Jacqueline Ramírez, Linda Janisch, Samir Undevia, Larry K. House, Soma Das et al. "Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the UGT1A1 Genotype of Patients With Cancer". Journal of Clinical Oncology 32, n.º 22 (1 de agosto de 2014): 2328–34. http://dx.doi.org/10.1200/jco.2014.55.2307.
Texto completoInnocenti, Federico, Ravi Salgia, Jacqueline Ramirez, Linda A. Janisch, Samir D. Undevia, Larry House, Soma Das et al. "A genotype-directed study to optimize dosing of irinotecan according to the UGT1A1 genotype." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 2570. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2570.
Texto completoRami, Avina, Steven G. DuBois y Kevin M. Campbell. "Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): 3149. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3149.
Texto completoLedwaba, Lehlogonolo P. I., Gerhard P. Hancke, Sherrin J. Isaac y Hein S. Venter. "Smart Microgrid Energy Market: Evaluating Distributed Ledger Technologies for Remote and Constrained Microgrid Deployments". Electronics 10, n.º 6 (18 de marzo de 2021): 714. http://dx.doi.org/10.3390/electronics10060714.
Texto completoPark, Jee Soo, Kyo Chul Koo, Doo Yong Chung, Sun Il Kim, Jeongho Kim, Cheol Kyu Oh, Tae Nam Kim et al. "Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma". Cancers 12, n.º 12 (2 de diciembre de 2020): 3602. http://dx.doi.org/10.3390/cancers12123602.
Texto completoRezaei, Mohsen, Rasoul Ajalloeian y Mohammad Ghafoori. "Comparison between deformation modulus of rock mass measured by plate jacking and dilatometer tests". Przegląd Naukowy Inżynieria i Kształtowanie Środowiska 26, n.º 3 (15 de septiembre de 2017): 317–25. http://dx.doi.org/10.22630/pniks.2017.26.3.31.
Texto completoBurnett, Alan K., David Bowen, Nigel Russell, Steven Knapper, Donald Milligan, Ann E. Hunter, Asim Khwaja et al. "AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial". Blood 122, n.º 21 (15 de noviembre de 2013): 622. http://dx.doi.org/10.1182/blood.v122.21.622.622.
Texto completoCeponis, Tomas, Stanislau Lastovskii, Leonid Makarenko, Jevgenij Pavlov, Kornelijus Pukas y Eugenijus Gaubas. "Study of Radiation-Induced Defects in p-Type Si1−xGex Diodes before and after Annealing". Materials 13, n.º 24 (12 de diciembre de 2020): 5684. http://dx.doi.org/10.3390/ma13245684.
Texto completoUmemura, Yoshie, Wajd Al-Holou, Bernard Marini, Denise Leung, Michelle Kim, Sean Ferris, Larry Junck et al. "CTNI-35. PHASE 0/1 TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH CHEMORADIATION TO OVERCOME TREATMENT RESISTANCE IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA BY TARGETING PURINE METABOLISM". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii79. http://dx.doi.org/10.1093/neuonc/noac209.300.
Texto completoTillmanns, Todd D., Mark E. Reed, Melissa C. Privett, Amanda L. Johns, Mark S. Walker y Arthur C. Houts. "Phase I trial of metronomic oral topotecan in combination with pazopanib utilizing a daily dosing schedule to treat recurrent or persistent gynecologic tumors." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): 5014. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.5014.
Texto completoWright, Karen, Cassie Kline, Mohamed Abdelbaki, David Ebb, Elias Sayour, Jennifer Elster, Sarah Leary et al. "CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii84. http://dx.doi.org/10.1093/neuonc/noac209.318.
Texto completoWaterhouse, David Michael, Jonathan Wade Goldman, Ben George, Peter J. O'Dwyer, Moncy Ye, Tianlei Chen, Nataliya Trunova y Karen Kelly. "Nivolumab (nivo) + nab-paclitaxel (nab-P) + carboplatin (C) in patients (pts) with non-small cell lung cancer (NSCLC): Interim results from a multicenter phase I study." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): 9095. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.9095.
Texto completoFury, M. G., J. Larkin, S. R. Gerst, P. Sabbatini, J. Konner, M. Orlando, D. F. Tai, T. Goss, C. Aghajanian y M. L. Hensley. "Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 14055. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.14055.
Texto completoVélez, Mónica Perea, Tine L. A. Verhoeven, Christian Draing, Sonja Von Aulock, Markus Pfitzenmaier, Armin Geyer, Ivo Lambrichts et al. "Functional Analysis of d-Alanylation of Lipoteichoic Acid in the Probiotic Strain Lactobacillus rhamnosus GG". Applied and Environmental Microbiology 73, n.º 11 (13 de abril de 2007): 3595–604. http://dx.doi.org/10.1128/aem.02083-06.
Texto completoMoehler, Markus H., Alexander Stein, Jorg Trojan, Jens Uwe Marquardt, Julia Quidde, Oliver Waidmann, Arndt Weinmann et al. "Regorafenib with TAS-102 (REGOTAS) in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)." Journal of Clinical Oncology 38, n.º 4_suppl (1 de febrero de 2020): 158. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.158.
Texto completoChakravarthy, A. B., F. Y. Wu, C. D. Blanke, J. D. Berlin, R. D. Beauchamp, H. Choy y D. Delbeque. "A phase I study of neoadjuvant paclitaxel/radiation in patients with potentially resectable adenocarcinoma of the pancreas". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 15067. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15067.
Texto completoFranklin, Anna, Marco Zecca, Franca Fagioli, Flavio Augusto Luisi, Gregory Song, Ajit Suri, E. Jane Leonard y Franco Locatelli. "Phase 1 Results from a Phase 1/2 Study to Assess the Safety, Tolerability and Recommended Phase 2 Dose (RP2D) of Brentuximab Vedotin Plus Doxorubicin, Vinblastine and Dacarbazine (A+AVD) in Pediatric Patients (Pts) with Advanced Stage Newly Diagnosed Classical Hodgkin Lymphoma (cHL)". Blood 132, Supplement 1 (29 de noviembre de 2018): 1644. http://dx.doi.org/10.1182/blood-2018-99-112488.
Texto completoGlasspool, Rosalind Margaret, Sarah Patricia Blagden, Michelle Lockley, James Paul, Carol Hopkins, Fiona Thomson, Jennifer Brown et al. "A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): 2594. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.2594.
Texto completoLee, S. M., D. Hershman, P. Martin, J. Leonard y K. Cheung. "Validation of toxicity burden score for use in phase I clinical trials". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 2514. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2514.
Texto completoFox, Elizabeth, Richard Aplenc, Rochelle Bagatell, Meredith K. Chuk, Eva Dombi, Wendy Goodspeed, Anne Goodwin et al. "A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors". Journal of Clinical Oncology 28, n.º 35 (10 de diciembre de 2010): 5174–81. http://dx.doi.org/10.1200/jco.2010.30.9674.
Texto completoSkolnik, Jeffrey M., Jeffrey S. Barrett, Bhuvana Jayaraman, Dimple Patel y Peter C. Adamson. "Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design". Journal of Clinical Oncology 26, n.º 2 (10 de enero de 2008): 190–95. http://dx.doi.org/10.1200/jco.2007.12.7712.
Texto completoRaymond, Eric, Valérie Boige, Sandrine Faivre, Ger-Jan Sanderink, Olivier Rixe, Laurent Vernillet, Christian Jacques, Michel Gatineau, Michel Ducreux y Jean-Pierre Armand. "Dosage Adjustment and Pharmacokinetic Profile of Irinotecan in Cancer Patients With Hepatic Dysfunction". Journal of Clinical Oncology 20, n.º 21 (1 de noviembre de 2002): 4303–12. http://dx.doi.org/10.1200/jco.2002.03.123.
Texto completoSawyer, Michael B., Mark J. Ratain, Donna Bertucci, Robert P. Smith, Richard L. Schilsky, Nicholas J. Vogelzang, Keith Shulman, Edwin C. Douglass y Gini F. Fleming. "Phase I Study of an Oral Formulation of ZD9331 Administered Daily for 28 Days". Journal of Clinical Oncology 21, n.º 9 (1 de mayo de 2003): 1859–65. http://dx.doi.org/10.1200/jco.2003.01.148.
Texto completoLong, Si, Yuhang Li, Junying Guo y Rong Hu. "Effect of the VivaSight double-lumen tube on the incidence of hypoxaemia during one-lung ventilation in patients undergoing thoracoscopic surgery: a study protocol for a prospective randomised controlled trial". BMJ Open 13, n.º 4 (abril de 2023): e068071. http://dx.doi.org/10.1136/bmjopen-2022-068071.
Texto completoBREITENSTEIN, O. "SCANNING-DLTS". Le Journal de Physique Colloques 50, n.º C6 (junio de 1989): C6–101—C6–110. http://dx.doi.org/10.1051/jphyscol:1989609.
Texto completo